NCRIS Health Group
Working together to keep Australians healthy through research innovation.
Health and medical researchers investigate solutions to complex problems that are often not easily solved by a single discipline. The NCRIS Health Group is aimed at enabling them collaboratively throughout the innovation and translational process.
Enabling Health Innovation and Translation
Health Group infrastructure
The Health Group offers seamless access to world class research infrastructure and expertise.
Governance
The NCRIS Health Group is a cross-capability collaboration established via a Collaboration Agreement. The Group is coordinated via a leadership group comprising the Board Chairs and Chief Executives of the ten member capabilities.
NCRIS Health Group Booklet
NCRIS Health Group Highlights
NCRIS Synthetic Biology Voucher Scheme 2026-27 (Round 2)
Through the National Collaborative Research Infrastructure Strategy (NCRIS) program, the Commonwealth committed $55M to Bioplatforms Australia in 2023 for a four-year program to provide a step change investment
Pipeline Accelerator 2025-26 (Round 2) successful recipients announced
Phenomics Australia in partnership with Therapeutic Innovation Australia (TIA), Bioplatforms Australia (BPA), and ANSTO’s National Deuteration Facility (NDF), is thrilled to announce the successful recipients of
Pipeline Accelerator 2025-26 (Round 1) successful recipients announced
Phenomics Australia in partnership with Therapeutic Innovation Australia (TIA), Bioplatforms Australia (BPA), and ANSTO’s National Deuteration Facility (NDF), is thrilled to announce the successful recipients of
Critical conversations and collaboration in Australian and European health research infrastructure
Phenomics Australia joins critical conversations about collaborative international research infrastructure at the 2025 Australian and European Health Research Infrastructure Symposium. The 2025 Australian & European Health
Pipeline Accelerator 2025-26 Round 1 Now Open
Applications for Pipeline Accelerator 2025-26 Round 1 vouchers are now open In this Pipeline Accelerator round, Phenomics Australia is partnering with TIA, ANSTO’s National Deuteration Facility
NCRIS Synthetic Biology Voucher Scheme
Bioplatforms Australia is pleased to announce that the NCRIS Synthetic Biology Voucher Scheme 2025-26 (Round 1) is now open for applications. In order to deliver sovereign
Pipeline Accelerator 2024-25 (Round 2) successful recipients announced
Phenomics Australia in partnership with Therapeutic Innovation Australia (TIA), Bioplatforms Australia (BPA), and the National Deuteration Facility (NDF), is thrilled to announce the successful recipients of
Phenomics Australia and Bioplatforms Australia support a National Initiative to develop the Australian Psychiatric Research Knowledge Bank
Phenomics Australia and Bioplatforms Australia are proud to announce a new national initiative aimed at advancing knowledge of the causality and treatment of mental disorders through
Pipeline Accelerator 2024-25 Round 2 Now Open
Applications for Pipeline Accelerator 2024-25 Round 2 vouchers are now open In this Pipeline Accelerator round, Phenomics Australia is partnering with Therapeutic innovation Australia (TIA), ANSTO’s